European Cancer Organisation

01/03/2026

At the European Cancer Summit 2025, Europe’s cancer community confronted a changing geopolitical and financial landscape with practical solutions and forward-looking strategies.

With negotiations for the upcoming EU long-term budget on the horizon, ECO’s Focus Topic Networks unveiled five major publications designed to move from commitment to concrete action, including:
✅ harnessing AI responsibly;
✅ improving cervical cancer screening;
✅ advancing survivorship policy; and
✅ optimising EU research investment.

The European Cancer Summit Report 2025 brings together all of these new releases, alongside the discussions that shaped them.

Download the report now 🔗 https://www.europeancancer.org/resources/publications/the-european-cancer-summit-report-2025-is-now-available

And mark your calendars now for the next European Cancer Summit:
📆 18 - 19 November 2026
📌 Brussels & online

27/02/2026

Liver cancer is the sixth leading cause of cancer-related deaths in Europe, with most cases caused by viral hepatitis. 👈

Tools to eliminate hepatitis exist, yet an estimated 4 in 10 Europeans are living with the disease unknowingly, having never been diagnosed. 🩺

To accelerate action, the WorldHepatitisAlliance, in partnership with EASL, ELPA and ECO, are organising a hybrid event at the European Parliament next month. 🗣️

Together we’ll discuss how to improve cancer prevention in the next Multiannual Financial Framework (2028-2034)! 🧩

📆 Tuesday 24 March
⌚ 13:30 – 15:00 CET
🔗 Register to attend at: https://www.worldhepatitisalliance.org/news/european-parliament/

27/02/2026

The human papillomavirus (HPV) is still often discussed as ‘just a women’s health issue’.

Not true. ❌

HPV can cause cancers in anyone. In men, it’s linked to cancers of the head and neck, a**s, and p***s. About 1 in 5 men globally have a current high-risk HPV infection, triggering an estimated 180,000 new HPV cancer cases each year. 👈

This is why gender-neutral vaccination is such a key public health strategy. Most European countries have already moved in this direction, but some still limit protection to girls only.

Reducing HPV-related cancers means protecting everyone. When both women and men are vaccinated, community protection increases and more deadly cancers can be prevented. 💉

Sources:

🔎 Worldwide burden of cancer attributable to HPV by site, country and HPV type: https://pmc.ncbi.nlm.nih.gov/articles/PMC5520228/
📢 Global Action on Men’s Health and NOMAN Is An Island, Report on Boys, Men and HPV: https://www.endhpvglobal.org/_files/ugd/8024e3_d55fe4899ca84ebbb5ac443f53c0e0aa.pdf
📢 PROTECT-EUROPE project: https://www.protect-europe.org/

27/02/2026

27/02/2026

The new Women & Cancer Policy Index scores national policies across Europe to assess how well countries respond to the specific needs of women affected by cancer.

From early detection to access to care, the Index identifies where progress is happening and where urgent action is still needed.

Fact: What gets measured gets improved!

Be part of the launch at the European Parliament.

🗓️ 17 March
🕥 10:45 – 12:00
📍 European Parliament, Room Spinelli 3H1

Register now to secure your place.

🔗https://europeancancer.org/events/413:women-and-cancer-launch-of-policy-index.html

26/02/2026

Extraordinary times demand extraordinary action. 🌟

In an era of political disruption and uncertainty, the European Cancer Summit 2025 brought together patients, healthcare professionals and policymakers to secure sustained political and financial support for cancer care and control.

Key discussions included
➡️ safeguarding the progress achieved through the Europe’s Beating Cancer Plan and the Cancer Mission;
➡️ harnessing artificial intelligence (AI) for oncology while balancing privacy and security concerns;
➡️ strengthening research investment frameworks; and
➡️ improving policies for cancer survivors across Europe.

All of these debates, commitments and key takeaways are captured in the newly released European Cancer Summit Report 2025.

Download your copy today 🔗 https://www.europeancancer.org/resources/publications/the-european-cancer-summit-report-2025-is-now-available

And mark your calendars now for the next European Cancer Summit:
📆 18 - 19 November 2026
📌 Brussels & online

26/02/2026

Please contribute to ’s survey. Help identify priorities for improving health literacy in cancer prevention, care, and survivorship.

If you’re a health professional, researcher, patient advocate, patient, or carer, please share your perspectives and help us understand what matters most.

🕒 10–15 minutes
🔒 Anonymous
📊 Your input will directly inform future education, practice, and policy

Survey closes on 28 February.
👉 https://forms.office.com/Pages/ResponsePage.aspx?id=DQSIkWdsW0yxEjajBLZtrQAAAAAAAAAAAAO__SU9klhUMTNISENWR1pKTExNNU1ZRkY1SVA4UVRERC4u&origin=QRCode

25/02/2026

It was a first – and one that will long be remembered. The European Cancer Screening and Early Detection Policy Summit brought together over 170 healthcare professionals, patient representatives, policymakers and other stakeholders in Brussels, with over 100 more following online. 🌟

As the projects PRAISE-U, SOLACE, and TOGAS come to a close, the delegates shared key findings and best practices – and pressed for more and better cancer screening policies across Europe.

To relive the event, check out the Summit picture gallery. 📸

Day 1 🔗https://www.facebook.com/media/set/?set=a.1365834462223602&type=3
Day 2 🔗https://www.facebook.com/media/set/?set=a.1365834952223553&type=3

25/02/2026

What have you heard about HPV vaccines? 💉

Some people question their safety, but the HPV vaccine has been used in Europe for decades and has been proven safe and effective, time and again. 👈

Today, more than 40 European countries are running national HPV vaccination programmes, and the vast majority of them include both girls and boys – ensuring everyone can be protected. 🌍

The evidence is clear: where proper vaccination and screening practices are well implemented, cancers caused by the human papillomavirus (HPV) are sharply reduced.

Help spread the word.

📘To learn more, read:

🔎 EPF Prevention Policy Atlas: https://www.epfweb.org/node/1171

📃 ECO Report on Cervical Cancer Screening: https://www.europeancancer.org/closing-gaps-cervical-cancer.html

🔬 Vaccines Work - The HPV vaccine is erasing cancer – here's the proof: https://www.gavi.org/vaccineswork/hpv-vaccine-erasing-cancer-heres-proof

25/02/2026

As the EU prepares its next Gender Equality Strategy, one question remains: Is cancer fully integrated into equality policy?

The new Women & Cancer Policy Index provides a benchmark for member states and EU institutions to measure progress and identify gaps.

Join us at the European Parliament to explore the findings and what they mean for future EU action.

🗓️ 17 March
🕥 10:45 – 12:00
📍 European Parliament, Room Spinelli 3H1

Seats are limited. Register today.

🔗https://europeancancer.org/events/413:women-and-cancer-launch-of-policy-index.html

24/02/2026

On 6 March, three EU-funded projects, UNCAN-Connect, CANDLE and EU-CiP, will host a joint webinar to explore who shapes the landscape of federated cancer research and cancer patient information. 🧩

In this interactive workshop, participants will work together to imagine and build personas representing key actors, such as:

💻 Digital infrastructure operators and analysts
🔬 Researchers
🥼 Healthcare professionals
🤝 Policymakers

The goal is to better understand their motivations, challenges and needs. 🔎

If you’re active in healthcare, patient advocacy, research, policy, industry, governance or digital infrastructures, this session is for you.

👉 Register here: https://emp.onl/cancerpersona

24/02/2026

AI has the potential to transform cancer care, but only if we ask ourselves the right questions now.

ECO’s Young Cancer Professionals are joining forces with European Oncology Nursing Society (EONS) to bring you: ‘Emerging technologies in cancer care – AI and digital health tools. What young professionals need to know’

As cancer continues to affect millions across Europe, understanding both the promise and the risk of artificial intelligence is essential. That’s why expert voices from clinical practice, research and global health are coming together to explore

➡️ how AI can advance oncology
➡️ what are its barriers, questions, and real-world challenges, and
➡️ how is the EU addressing the associated risks and responsibilities

Join us for this timely discussion!

📅 Tuesday 3 March
🕓 16:00 to 17:30 CET
💻 Online

Register now 🔗 https://www.europeancancer.org/events/406:emerging-technologies-in-cancer-care-ai-and-digital-health-tools.html